Denied

No. 24-1210

Brent Andrew Brackett Arbogast v. Pfizer Inc., as Successor to Wyeth Pharmaceuticals, et al.

from the United States Court of Appeals for the First Circuit

See other cases from the First Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of 9/29/2025.

Waiver of right of respondents Pfizer, Inc., Leigh Cowdrick, John Brack and Kerri Lewandowski to respond filed.

Waiver of right of respondents Thomas M. Clossen, Micheal J. Lambert, and Sheehan, Phinney, Bass & Green, P.A. to respond filed.

Petition for a writ of certiorari filed. (Response due June 30, 2025)

Application (24A609) granted by Justice Jackson extending the time to file until March 3, 2025.

Application (24A609) to extend the time to file a petition for a writ of certiorari from January 2, 2025 to March 3, 2025, submitted to Justice Jackson.

Parties

Brent Arbogast, Petitioner, represented by Brent Andrew Brackett Arbogast

Pfizer, Inc., Leigh Cowdrick, John Brack and Kerri Lewandowski, Respondent, represented by Bejamin Davis

Thomas M. Clossen, Micheal J. Lambert, and Sheehan, Phinney, Bass & Green, P.A., Respondent, represented by Linda M. Smith

 
Last updated: April 18, 2026